Small cap round up
Digital media content provider One Media iPGroup announced on Wednesday that it has renewed the exclusive rights to the MDProduction music catalogue, for a recoupable advance of $18,000.The AIM-traded firm said the MD catalogue comprises more than 1,000 original recordings from the 1960s to the 1980s, and artists such as Don Fardon, The Cockerel Chorus, Dando Shaft, Gill Scott-Heron, Greyhound, Roy Harper, Johnny Kidd & the Pirates, Kenny and Python Lee Jackson and others.
Multimedia company Johnston Press, owner of brands like The Scotsman and The Yorkshire Post, has won a contract to print the Monday to Saturday issues of the Daily Mail for an undisclosed sum. The agreement comes after Associated Newspapers, a wholly owned subsidiary of DMGT responsible for production of the Mail, closed its print sire at Didcot, Oxfordshire.
Diversified mineral exploration and development company Sunrise Resources advised the market of the commissioning of a concept study on Wednesday, for the development of its CS natural pozzolan project in Nevada and to provide further details of the work programme proposed for the first half of 2017. The AIM-traded firm said natural pozzolans were seeing increased use in cements and concrete as a ‘greenhouse gas friendly’ alternative to Portland cement.
Shares in Taptica International surged after the end-to-end mobile advertising platform said that it anticipates revenue and earnings will be ahead of expectations, after better-than-expected growth in the last two months of 2016. The AIM-listed company anticipates revenue for the 2016 calendar year to be ahead of expectations, with a 65% increase to at least $125m, compared to the previous year.
Kromek, a radiation detection technology company, raised £21m in equity in order to support commercial activity and grow the business.The AIM-listed company raised the funds from a firm placing, which was oversubscribed from new and existing investors, and an open offer, both subject to shareholder approval.
Neuroscience digital health company Cambridge Cognition has gained regulatory clearance for its memory test to be used as a medical device in the US. Cantab Mobile, which detects clinically-relevant memory impairment in older adults at the point of care, received 510k clearance for the US Food and Drug Administration to be marketed a medical device.